Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 21 for:    semaglutide + STEP 3 | Phase 3
Previous Study | Return to List | Next Study

Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program (STEP 3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03611582
Recruitment Status : Completed
First Posted : August 2, 2018
Last Update Posted : March 8, 2021
Sponsor:
Information provided by (Responsible Party):
Novo Nordisk A/S

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 18, 2020
Actual Study Completion Date : April 28, 2020
Certification/Extension First Submitted : March 3, 2021